The article focuses on the characteristics of phosphatidylinositol 3-kinase (PI3 kinase) in treating brain tumors. A recent study showed a proof that the exciting potential of compounds that inhibit PI3 kinase and mTOR for the treatment of malignant brain tumors. The PI3 kinase pathway can control a range of cellular processes, including cell growth, survival, differentiation, chemotaxis and metabolism.